Company facts
- Headquarters
- Newton, Massachusetts
- Most recent report
- 8-K, filed Nov 5, 2026
- Incorporated
- Delaware
- Filings on record
- 365 filings
- On EDGAR
- CIK 1576885
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 22
News 8 of 57
- 8-K Current report on a material event Nov 5, 2026
- 8-K Other events Oct 30, 2026
- 8-K Quarterly results Oct 26, 2026
- 8-K Current report on a material event Sep 16, 2026
- 8-K Quarterly results Aug 12, 2026
- 8-K Other events Jun 16, 2026
- 8-K Shareholder vote results Jun 3, 2026
- 8-K Quarterly results May 12, 2026
Prospectuses and Registrations 8 of 19
- S-3 Shelf registration statement Oct 26, 2026
- S-8 Registration statement for an employee plan Aug 12, 2026
- 424B3 Prospectus supplement for an offering Apr 1, 2026
- S-3 Shelf registration statement Mar 26, 2026
- S-8 Registration statement for an employee plan Mar 26, 2026
- 424B5 Prospectus supplement for an offering Nov 13, 2025
- S-8 Registration statement for an employee plan Mar 27, 2025
- S-3 Shelf registration statement Mar 27, 2024
Proxies 8 of 11
- DEFA14A Extra proxy material Apr 23, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2026
- DEFA14A Extra proxy material Apr 23, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2025
- DEFA14A Extra proxy material Apr 22, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2024
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2023
Ownership 8 of 222
- 4 Insider reported a trade Jun 17, 2026
- 144 Notice of a proposed sale of restricted stock Jun 17, 2026
- 144 Notice of a proposed sale of restricted stock Jun 16, 2026
- 144 Notice of a proposed sale of restricted stock Jun 15, 2026
- 4 Insider reported a trade Jun 10, 2026
- 144 Notice of a proposed sale of restricted stock Jun 9, 2026
- 4 Insider reported a trade Jun 5, 2026
- 4 Insider reported a trade Jun 5, 2026
Other 8 of 34
- EFFECT Notice that a registration became effective Oct 28, 2026
- DRS Draft registration statement, submitted confidentially Aug 12, 2026
- ARS Annual report sent to shareholders Apr 23, 2026
- EFFECT Notice that a registration became effective Apr 1, 2026
- CORRESP Reply to SEC staff Mar 30, 2026
- UPLOAD Comment letter from SEC staff Mar 30, 2026
- ARS Annual report sent to shareholders Apr 23, 2025
- EFFECT Notice that a registration became effective Apr 24, 2024
Everything here comes from Acumen Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.